Should I Buy BRBR? BRBR 2026 Analysis

Should You Buy Bellring Brands Inc (BRBR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

19.520

1 Day change

0.21%

52 Week Range

79.570

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now: price is in a clear downtrend and has slipped below the first key support (S1 ~21.53) with the next support near ~19.60.
Bearish sentiment is reinforced by heavy put volume (put-call volume ratio extremely high) plus hedge fund and insider selling.
Recent earnings/news flow is negative (guidance tightening, profitability deterioration, class action headlines, CEO retirement), which can keep pressure on the stock despite oversold readings.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Technical Analysis

Trend: Bearish (SMA_200 > SMA_20 > SMA_5) indicating sustained downside momentum.
Momentum: MACD histogram at -0.18 and negatively expanding → downside momentum is strengthening.
RSI: RSI_6 at ~18.2 (deep oversold) → bounce potential exists, but oversold can persist in strong downtrends.
Key levels: Pivot 24.64 (well overhead); Resistance R1 27.75 / R2 29.67; Support S1 21.53 (now broken) and S2 19.60 (next downside area).

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

Sentiment: Despite a call-heavier open interest (OI put/call 0.73), today’s trading flow is very bearish (put-call volume ratio 13.51; put volume 12,725 vs call volume 942).
Volatility: 30D IV ~53.09 vs historical vol ~32.02; IV percentile 81.6 → options are pricing elevated uncertainty/fear.
Activity spike: today’s volume vs 30D average ~724.66% and open interest elevated → suggests event-driven hedging/speculation skewed to puts.

Technical Summary

Sell

Buy

Positive Catalysts

- Deeply oversold RSI may attract short-term mean-reversion buyers.
- Q1 FY2026 net sales still grew slightly (+0.83% YoY) and guidance was narrowed (less uncertainty than a broad range).
- Some analysts remain constructive long-term (multiple Buy/Overweight ratings remain despite lower targets).

Neutral/Negative Catalysts

- Earnings quality deterioration: Q1 FY2026 net income -43% YoY, EPS -39% YoY, and gross margin meaningfully lower.
- Guidance/forward outlook concerns: news highlights a disappointing sales outlook and challenging channel trends.
- Legal overhang: securities class action headlines can weigh on sentiment and keep volatility elevated.
- Management transition: CEO retirement adds uncertainty during a difficult operating backdrop.
- Flows: Hedge funds selling (selling amount +224.53% last quarter) and insiders selling (selling amount +1274.74% last month).
- Options tape is aggressively bearish (put-heavy volume), aligning with the current downtrend.

Financial Performance

Latest quarter: 2026/Q1.
Revenue: $537.3M, +0.83% YoY (growth has slowed to ~flat).
Profitability: Net income $43.7M, -43.17% YoY; EPS $0.36, -38.98% YoY.
Margins: Gross margin 29.13, down ~20.56% YoY → indicates rising costs/price pressure and/or mix competition.
Overall: Top-line holding up slightly, but profitability and margin compression are the key negative trend.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Broad wave of price target cuts from multiple firms following/around the Q1 print and tougher category setup.
Latest actions: Barclays cut PT to $27 (keeps Overweight); DA Davidson cut to $32 (keeps Buy); Deutsche Bank cut to $31 (keeps Hold) and previously downgraded to Hold; Morgan Stanley cut to $32 (keeps Overweight); TD Cowen cut to $27 (keeps Hold); Mizuho previously cut but kept Outperform.
Wall Street pros: Long-term category growth (protein/CPG), potential to hold share over time, some Overweight/Buy ratings remain.
Wall Street cons: Near-term consumption/merchandising inflection not showing up, competitive/private label pressures, and a tougher staples demand backdrop—hence lower targets and more “wait-and-see” framing.
Influential/politician activity: No recent congress trading data available; no politician buy/sell information provided.

13 Analyst Rating

Wall Street analysts forecast BRBR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BRBR is 39.17 USD with a low forecast of 27 USD and a high forecast of 52 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

9 Buy

4 Hold

0 Sell

Moderate Buy

Current: 19.480

Low

Averages

39.17

High

Current: 19.480

Low

Averages

39.17

High

Barclays

Andrew Lazar

Overweight

maintain

$30 -> $27

AI Analysis

2026-02-05

New

Reason

Barclays

Andrew Lazar

Price Target

$30 -> $27

AI Analysis

2026-02-05

New

maintain

Overweight

Reason

Barclays analyst Andrew Lazar lowered the firm's price target on BellRing Brands to $27 from $30 and keeps an Overweight rating on the shares. The firm say say the company's narrowing the upper end of its fiscal 2026 sales and EBITDA guidance acknowledges what Street estimates already imply - that the "land grab" by insurgent protein shake brands has elevated promotional frequency.

Stifel

Buy

downgrade

$50 -> $34

2026-02-04

New

Reason

Stifel

Price Target

$50 -> $34

2026-02-04

New

downgrade

Buy

Reason

Stifel lowered the firm's price target on BellRing Brands to $34 from $50 and keeps a Buy rating on the shares. BellRing brands reported a stronger first quarter, but the stock underperformed despite low expectations into the quarter, which the firm believes reflects a softer second quarter outlook and lowered FY26 guidance that is still second-half weighted, the analyst tells investors.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BRBR

Unlock Now

BRBR Should I Buy

BRBR Should I Buy

Should You Buy Bellring Brands Inc (BRBR) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch